Why the study?
Flecainide dysrhythmias are often refractory to antiarrhythmics and cardioversion, commonly requiring extracorporeal support.
Aggressive multimodal management with sodium bicarbonate and 20% intravenous lipid emulsion can successfully treat severe flecainide toxicity in pediatric patients, potentially avoiding the need for extracorporeal support.
Successful pediatric flecainide toxicity resuscitation; hypothesis-generating and should not yet change practice.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics and cardioversion, and patients commonly require extracorporeal support. We review the successful resuscitation of two brothers aged 2 and 4 who presented two years apart with unstable wide-complex tachyarrhythmia suspicious for severe flecainide toxicity. Each patient received sodium bicarbonate and 20% intravenous lipid emulsion with a full recovery. While extracorporeal support is often required following flecainide ingestion, we present two cases where it was avoided due to aggressive multimodal management with sodium bicarbonate, electrolyte repletion, and 20% intravenous lipid emulsion. In addition, avoidance of agitation-induced tachycardia may be beneficial.
No takes yet. Share an insight, caveat, or question.
Yelton et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: